Patents by Inventor Kevin A. Bray

Kevin A. Bray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20250064913
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Application
    Filed: September 11, 2024
    Publication date: February 27, 2025
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
    Patent number: 12115216
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Grant
    Filed: December 15, 2022
    Date of Patent: October 15, 2024
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20230270837
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Application
    Filed: December 15, 2022
    Publication date: August 31, 2023
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
    Patent number: 11559576
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Grant
    Filed: August 13, 2020
    Date of Patent: January 24, 2023
    Assignee: Regeneran Pharmaceuticals, Inc.
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20220251215
    Abstract: The present disclosure provides antigen-binding proteins that specifically bind to an H LA-displayed New York esophageal squamous cell carcinoma 1 (NY-ESO-1) peptide, and therapeutic and diagnostic methods of using those binding proteins. The antigen-binding proteins of the present disclosure bind with a high degree of specificity to HLA-displayed NY-ESO-1 and do not bind to HLA-displayed peptides that differ by 2, 3, 4, 5 or more amino acids.
    Type: Application
    Filed: July 2, 2020
    Publication date: August 11, 2022
    Inventors: Kevin A. Bray, Frank Delfino, David Dilillo, Matthew C. Franklin, Jessica Kirshner, Douglas MacDonald
  • ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20220001000
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Application
    Filed: August 13, 2020
    Publication date: January 6, 2022
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
    Patent number: 10806780
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: October 20, 2020
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica R. Kirshner, Douglas MacDonald, William Olson, Gavin Thurston
  • ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20190000956
    Abstract: The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.
    Type: Application
    Filed: June 27, 2018
    Publication date: January 3, 2019
    Inventors: Kevin A. Bray, Frank Delfino, Matthew C. Franklin, Elena S. Garnova, Jessica R. Kirshner, Douglas MacDonald, William Olson, Gavin Thurston